HempNewsBreaks – MCTC Holdings, Inc. (MCTC) to Host Hemp You Can Feel(TM) Alcohol-Free Cocktails Launch Event for LA Press

MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced an upcoming press event it plans to host on March 12, 2020, to introduce its new Hemp You Can Feel(TM) Alcohol-Free cocktails. The event will feature some of the Los Angeles area’s best bartenders and servers as they mix up both classic and new age hemp-infused cocktails based on MCTC’s next-generation all-natural hemp extract and CBD beverage infusion technologies. “When was the last time you were able to relax with a cocktail, but not have to worry about the negative effects of alcohol?” MCTC Chief Executive Officer Arman Tabatabaei said in the news release. “We have invented something truly extraordinary with our Hemp You Can Feel(TM) technology – In fact, it is so unique, we have filed several patents on the underlying technologies. We invite all area presses to be among the first to try these all-natural hemp extract and CBD cocktails.”

To view the full press release, visit http://cnw.fm/RO1fI

About MCTC Holdings, Inc.

MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. More information on the Company can be viewed at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) PharmHouse Receives Health Canada License Amendment for Cultivation Across Entire Greenhouse

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its 49%-owned joint venture in Leamington, Ontario, PharmHouse Inc., received a license amendment from Health Canada allowing for cultivation across its entire greenhouse, which is now fully operational. According to the update, PharmHouse plans immediate ramp up in production in accordance with its offtake agreements with Canopy Growth Corporation and TerrAscend Canada Inc. Under these agreements, PharmHouse has committed 50% of its 2020 output and currently expects to use the remaining 50% of its capacity for both additional offtake agreements and its own private label brand. “The receipt of our license amendment represents a large milestone for PharmHouse,” PharmHouse General Manager Tony Abbas said in the news release. “This is a reflection of the hard work and dedication that our team has put in this past year and we are all very excited for this next chapter. Since the inception of PharmHouse, it has been our goal to bring innovation and consistency to greenhouse cannabis cultivation. With our full production capacity available to us and with the experience and market presence of our partners, we hope to change the industry concept of commercial cannabis production.”

To view the full press release, visit http://cnw.fm/RcP6i

About Canopy Rivers

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire portfolio. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Chair, Paul Lucas, Recipient of Life Sciences Ontario’s Lifetime Achievement Award

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that its chair of its board of directors, Paul Lucas, is the receipt of the 2020 Lifetime Achievement Award from Life Sciences Ontario. The award recognizes Lucas’ exceptional leadership and contributions to the development of the life sciences sector in Canada, his commitment to the community and his passion for improving the quality of life for Canadians. “We are proud and honoured to have the benefit of Paul’s knowledge and expertise as we continue to grow VIVO’s business,” VIVO CEO Barry Fishman said in the news release. “Paul’s career is marked by outstanding achievements, unwavering dedication and commitment to the life sciences community. We are incredibly fortunate to have Paul as the Chair of VIVO, setting the standard for integrity, strategic focus and governance in this nascent industry.”

To view the full press release, visit http://cnw.fm/jI7ri

About VIVO Cannabis(TM)

VIVO, based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine service. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VIVOCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VIVO

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Trial Shows Medical Marijuana Can Treat Insomnia

Zelira Therapeutics has developed a medical marijuana insomnia product known as Thunderbird. Zelira Therapeutics was previously called Zelda Therapeutics (ASX: ZLD), and it changed its name after merging with the USA’s Ilera Therapeutics LLC late last year.

For the past few years, Zelda, currently known as Zelira Therapeutics, has been working on a marijuana product used for treating insomnia, ZLT-101. In 2017, Zelda Therapeutics obtained approval to conduct clinical trials with patients who have chronic insomnia in Australia. At the time of the merger, Zelda Therapeutics was also studying the use of marijuana in treating conditions such as autism, cancer, and opioid reduction, and it will continue to do so under the new company.

Zelira Therapeutics has operations both in the U.S. and Australia, and this gives it a robust platform in the global medical marijuana market.

On Wednesday, Zelira Therapeutics announced that it had completed phase 1b/2a of the clinical trials of ZLT-101. The study findings reveal that 23 patients who had chronic insomnia and were treated using ZLT-101 demonstrated statistical improvement in the Insomnia Severity Index (ISI) scores when they were compared with those who used the placebo. Patients who used ZLT-101 showed high tolerance since no adverse effects were reported.

Although ZLT-101 was well tolerated, some patients said that they experienced the following side effects; dry mouth, which was preceded by dizziness, headache, and feeling unwell. Out of the 23 patients using ZLT-101, 17 reported having experienced these mild side effects. Four participants who were placed on the placebo also said that they experienced the same side effects.

Zelira Therapeutics said that all adverse events that were noted during the clinical trials were classified as mild, and 97.5% of the cases had resolved overnight or as soon as the patient woke up the following day or were resolved at the end of the clinical trial.

Zelira said that lack of severe or persistent mild adverse cases is encouraging, given those linked with other insomnia therapies.

Prof. Peter Eastwood, who was the Principal Investigator for the study, said that it was impressive for the ZLT-101 treatment to achieve a statistically significant improvement in ISI scores, given the relatively short two-week dosing window. Prof. Eastwood is also the director of the Centre for Sleep Science, which is based at the University of Western Australia.

Although the clinical trial findings won’t be published until the end of March 2020, the Chairman of Zelira Osagie Imasogie said that the company can now commercialize ZLT-101 across the globe this year.

Patients who have chronic insomnia have challenges sleeping or staying asleep. They do not feel refreshed even after adequate sleep, and they also suffer from impairment during their day-to-day activities for a minimum of four weeks.

It is widely expected that other marijuana industry players, such as SinglePoint Inc. (OTCQB: SING), are happy that these research findings are positive since they add to the increasing body of evidence proving the therapeutic effects of marijuana on various health conditions.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – New Mexico Moves to End Access to Medical Marijuana by Non-Residents

New Mexico has ruled out the enrollment of non-resident in their medical marijuana program. This week, New Mexico governor Michelle Lujan Grisham signed into law a bill that denies issuance of medical marijuana cards to non-residents.

Last year the state approved a change in statute, which was signed by the governor, allowing out of state patients to enroll in the state’s medical marijuana program. And since September, more than 600 patients from Texas, Arizona, and other states have enrolled in the New Mexico medical marijuana program. Under the new law, the patients will not be able to renew their medical marijuana cards in New Mexico, but under the reciprocity rule, they will still be able to buy medical marijuana in New Mexico using their state’s medical marijuana cards.

New Mexico health officials later backtracked and said that the residency requirement provision was removed from the legislation unintentionally. They requested the lawmakers to reinstate the residency requirement this year and claimed that opening the state medical marijuana program to other states might attract federal intervention. Interstate transportation of marijuana is still illegal, and allowing non-residents access to the state’s medical marijuana program might tempt people to transport weed across the borders illegally.

On Monday, New Mexico approved the reinstatement of the residency requirement in a vote of 44-19. The state’s largest medical marijuana distributor, Ultra Health, was against the restoration of the residency requirement. The New Mexico governor also signed reciprocity rules allowing patients with medical marijuana cards from other states to access medical marijuana from New Mexico dispensaries.

The CEO of Ultra Health Duke Rodriguez challenged the claim of federal intervention before the lawmakers, noting that out of state patients adhere to the terms of New Mexico’s medical marijuana program as they seek relief from their health ailments such as cancer and other medical conditions that require marijuana prescriptions.

Speaking to the House committee on health policy, Rodriguez said that there is no threat of federal intervention.

Last year, Ultra Health went to court to compel the state to issue medical marijuana cards to non-residents and succeeded; however, their success was short-lived since the state approved a law reinstating the residency requirement. Ultra Health has more than 20 dispensaries within the state, and it has been in conflict with the state’s Health Department because it is pushing for an increase in marijuana production caps to ensure that the supply is sufficient to serve the patients.

During the residency reinstatement vote, Democratic House Speaker Brian Egolf excused himself from the debate and the vote since he represents Ultra Health as a private attorney.

Non-residents who are already enrolled in the state’s medical marijuana program and have medical marijuana cards would be allowed to use their cards for a period of three years with no chance of renewal, said the state’s Health Secretary Kathyleen Kunkel.

Four states border New Mexico, and all have legalized medical marijuana, but Texas is notable for only allowing the sale of medical marijuana containing low THC levels. And Colorado has legalized the recreational sale and use of marijuana.

It remains to be seen whether other sector players, such as HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF), will react to this measure that appears to take New Mexico a step back on matters of marijuana policy reform.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

HempNewsBreaks – Youngevity International, Inc.’s (NASDAQ: YGYI) Khrysos Industries Hosts First HIAF Educational Event of 2020 at its Orlando-Based Headquarters

Youngevity International (NASDAQ: YGYI) together with its subsidiary and hemp enterprise, Khrysos Industries, Inc., today announced that Khrysos, on Thursday, hosted the first educational and networking event of 2020 for the Hemp Industry Association of Florida (“HIAF”) at its Orlando-based headquarters. According to the update, industry leaders from Florida’s hemp sector and other HIAF board members were treated to a “Hemp Extraction Lab Tour & Workshop” at Khrysos Industries, which operates the largest processing facility in Florida. HIAF, state and federal regulatory updates were also provided during the event. “It was a high honor to host the first HIAF educational event of 2020 and to have the chance to share our vision and capabilities with Florida’s leaders in the Hemp Industry,” YGYI President and CFO Dave Briskie said in the news release. “Dwayne Dundore gave a fantastic presentation and a large group of influencers learned all about Khrysos Industries and its significant capabilities.”

To view the full press release, visit http://cnw.fm/T75ng

About Youngevity International, Inc.

YGYI, Inc. (NASDAQ: YGYI), is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, YGYI offers products from the eight top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo, as well as innovative services. The company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution(R) Coffee company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For investor information, please visit www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI

About HempWireNews

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) CEO Discusses Launch of Two New Products on MoneyTV with Donald Baillargeon

ChineseInvestors.com (OTCQB: CIIX) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program, viewed in over 200 million households and more than 75 countries, covers money-focused topics and features in-depth interviews with CEOs and executives that offer insights into various companies and their operations and future outlooks. Among other highlights, this week’s program featured CIIX CEO Warren Wang as he analyzed the impact of the Coronavirus scare. He discussed the launch of two new products through the company’s China-based subsidiary, CBD Biotech, including a CBD hemp gel as well as a spray, designed to create an isolating mist for consumers in public places.

To view the full press release, visit http://cnw.fm/A6w85

About ChineseInvestors.com Inc.

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company by providing (a) real-time market commentary, analysis and educationally related services in both traditional and simplified Chinese language character sets; (b) advertising and public-relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health-related products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

420 with CNW – Colorado Pot Sales Hit New Record

This week, the Colorado Department of Revenue released new data that showed that the dispensaries within the state set a new sales record in 2019.

The state of Colorado raked in $1.74 billion in medical and adult-use marijuana sales, out of which $302 million was collected in the form of sales taxes. The tax proceeds within the state are used in the construction of new schools and health education programs.

Compared to 2018, marijuana sales in the state of Colorado increased by 13% in 2019. Colorado was among the first states to legalized marijuana in the U.S, and since 2014, Colorado has generated a total of $7 billion in legal marijuana sales. And since 2014, the state’s legal marijuana industry has made a total of $1.21 billion in tax proceeds.

In December 2019, the state of Colorado sold more than $144 million of marijuana products, which is a 6.7% increase from the previous month. But, August was the most lucrative within the state in all of 2019, because the state’s legal marijuana businesses sold weed worth $173 million.

Colorado Governor Jared Polis is an avid supporter of legal marijuana because it has brought a lot of economic benefits to his state. And while speaking at a CNBC event, Polis said that the industry is performing well within the state as it has created many employment opportunities, raised revenue for Colorado, and buildings are being rented out, giving the landlords business. He has also witnessed a reduction in the crime rate.

Analysts predict that the booming marijuana industry is just getting ready for a takeoff, and this prediction coincides with strong marijuana sales.

In the whole of the U.S., the employment opportunities in the legal cannabis industry hiked up to a quarter of a million people in 2019, and analysts predict that the legal marijuana industry might overtake the illicit market soon.

Marijuana is still a federally controlled substance, and there are strict restrictions for companies when it comes to advertising marijuana. The national marketing of marijuana is prohibited, but state regulators are given the mandate to establish the rules for promoting cannabis products locally.

The restrictions have forced companies to be creative in coming up with ways to reach their target customers.

For instance, 51 dispensaries and manufacturers have adopted a clean road initiative where they are sponsoring approximately 66% of Colorado state highways.

In exchange for a sign, businesses and individuals through Colorado’s Department of Transportation Clean Colorado, Sponsor-a-Highway program, offer to pay a clean-up fee to keep the roads litter-free.

Such initiatives to give back to the community are seen by analysts as proof that what sector players like Champignon Brands Inc. and ChineseInvestors.com (OTCQB: CIIX) have always pointed out as the positive knock-on effects of legalizing this industry.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Risks of Buying Marijuana from Unregulated Sources

It would be pointless to make mistakes or make yourself sick while cultivating marijuana as if there were no rigorous controls at an approved professional cultivation facility. On rare occasions, marijuana products might be contaminated, and their health benefits might turn to be health hazards.

For this reason, you should buy marijuana products from licensed dispensaries and also avoid growing your own marijuana if you do not know what you are doing. This will minimize the risks of consuming contaminated cannabis.

Discussed below are some of the contaminants that can be found in untested marijuana products.

Mold

Marijuana, which is ready to be consumed, should never feel damp, wet, or gooey. If your cannabis is wet or squishy, it must be holding water, which is an issue as it can be a breeding ground for mold, as mold grows in moist places.

Botrytis cinerea is a type of fungus that causes marijuana buds to rot. Although it is not toxic, in some cases, it can lead to a respiratory allergic reaction known as hypersensitivity pneumonitis, which causes inflammation of the alveoli. Even if it is rare, hypersensitivity pneumonitis can be severe. And common symptoms are coughing, fever, and labored breathing.

Heavy Metals Found in the Soil

These include cadmium, arsenic, lead, mercury, and uranium. The presence of minerals in the soil depends on the location; therefore, farmers should survey their land before cultivating marijuana because marijuana roots can suck up and retain the heavy metals as well as other chemical contaminants. A study conducted in 2002 and published in Industrial Crops and Products found that the highest concentration of the minerals was accumulated in the leaves, seeds, and fibers.

Pathogens

These are bacteria, fungi, viruses, and other microorganisms that cause illness, and they include rhinovirus and coronavirus.

A report released by the Cannabis Safety Institute stated that pathogen bacteria could not be associated with living marijuana plants because living marijuana plants do not support a high concentration of bacteria growth. The report also noted that pathogenic bacteria that are extremely resistant to drying could survive on marijuana and eventually be transferred to humans through marijuana consumption.

Salmonella is the pathogenic bacteria that can survive when marijuana is dried, and it is transferred to people through inhalation. It causes severe fevers and fatigue, and it is not easily diagnosed.

Other types of pathogens include Aspergillus, which is found in both indoor and outdoor environments. It can cause harmful lung infections. E-coli is another type of bacteria that is found in poop and contaminates everything that comes into contact with poop. It can cause diarrhea and lung infections.

Pesticides

Pesticides are a double-edged sword because they make cultivation of commercial marijuana possible, but they can also be harmful if the products retain too much of it. For instance, in October, Oregon called back two batches of cannabis (Dr. Jack, batch no. G6J0051-02, and Marionberry, batch no. G6J0051-01) because it was found that they had high pesticides residuals known as spinosad after they were tested.

Spinosad causes irritation and redness if it comes into contact with your skin or eyes.

Controlled Substances

Marijuana products found on the black market may be laced with illicit substances such as phencyclidine or opiates. This is done to trick consumers into thinking they are buying high-quality marijuana. And this can create dependence in their buyers since they are not aware that the products are infused with other addictive drugs.

To reduce the risk of buying contaminated marijuana products, make sure that you are purchasing only from registered marijuana dispensaries. Experts think that this need for care could explain why cannabis companies like Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) encourage consumers to read third-party lab reports before purchasing any marijuana product.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Why Champignon Brands Inc. Is ‘One to Watch’

Headquartered in Vancouver, British Columbia, Champignon Brands is a research-driven company with a wide-ranging portfolio of artisanal mushroom health supplements designed with the health-conscious consumer in mind. A recent article discussing the company reads, “Champignon’s mushroom-derived, consumer packaged goods (‘CPGs’) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their well-being one cup of mushroom-infused tea at a time. . . . Also in the portfolio are Nourish Force Supertea, a blend of reishi ryobus tea mix; Mighty Recharge Supertea, created with lion’s mane tropical green ginseng tea mix; and Brain Enhance Supertea, a blend of cordycep hibiscus and berries tea mix — all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.”

To view the full article, visit http://cnw.fm/m4W6L

About Champignon Brands Inc.

Champignon Brands is a research-driven company specializing in the formulation and distribution of a suite of artisanal-mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind. For more information, visit the company’s website at www.ChampignonBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to Champignon are available in the company’s newsroom at http://cnw.fm/Champignon

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com